V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260016926 | 260009825 | 1.79 | 65.7 | Curative (C) | 2016-05-14 | 2016-05-16 | CARBO + THIOTEPA + TOPOTECAN | 2 | N | 260029719 | CARBOPLATIN + THIOTEPA + TOPOTECAN |
| 260016927 | 260009829 | null | 85.4 | Curative (C) | 2016-11-07 | 2016-11-11 | CARBO + THIOTEPA + TOPOTECAN | 2 | N | 260029725 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260016928 | 260009830 | null | 82 | Adjuvant (A) | 2017-04-29 | 2017-04-30 | CISPLATIN + GEMCITABINE + RITUXIMAB | 2 | N | 260029728 | TRASTUZUMAB |
| 260016929 | 260009833 | 1.62 | 51.4 | Palliative (P) | 2013-11-25 | 2013-12-01 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 260029745 | CARBOPLATIN + PACLITAXEL |
| 260016930 | 260017035 | 1.72 | 91 | Curative (C) | 2013-12-02 | 2013-12-23 | GEMCARBO | N | N | 260029746 | EP |
| 260016931 | 260009836 | 1.76 | 71.6 | Curative (C) | 2015-07-09 | 2015-07-09 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE | 2 | N | 260029747 | CISPLATIN |
| 260016932 | 260009836 | 1.7 | 65 | Curative (C) | 2018-03-27 | 2018-03-27 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 260029747 | BLEOMYCIN + VINCRISTINE |
| 260016933 | 260009837 | 1.6 | 87.5 | Curative (C) | 2018-07-24 | 2018-10-08 | CISPLATIN + EPIRUBICIN | N | N | 260029754 | CARBOPLATIN + CYCLOPHOSPHAMIDE + ETOPOSIDE |
| 260016934 | 260009839 | 1.59 | 47.6 | Curative (C) | 2018-04-05 | 2018-04-06 | CHOP - 21 days | 02 | N | 260029759 | CARBOPLATIN + PACLITAXEL |
| 260016935 | 260009840 | 1.73 | 80.5 | Curative (C) | 2018-05-31 | 2018-11-01 | IFOSFAMIDE + PACLITAXEL | 02 | N | 260029767 | GEMCITABINE + OXALIPLATIN + PACLITAXEL |
| 260016936 | 260014680 | 1.6 | 77.7 | Palliative (P) | 2018-04-18 | 2018-09-14 | CISPLATIN + GEMCITABINE + RITUXIMAB | N | N | 260029816 | PEMETREXED |
| 260016937 | 260009845 | 1.63 | 78.6 | Palliative (P) | 2015-07-16 | 2015-07-17 | Cisplatin + Radiotherapy | 2 | N | 260029822 | CETUXIMAB |
| 260016938 | 260017040 | 1.88 | 102 | Adjuvant (A) | null | 2018-04-23 | IFOSFAMIDE + PACLITAXEL | N | N | 260029823 | IFOSFAMIDE + PACLITAXEL |
| 260016939 | 260009846 | 1.8 | 119 | Curative (C) | 2015-07-06 | 2015-07-10 | ACE (germ cell) | 02 | N | 260029834 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 260016940 | 260009851 | 1.74 | 98 | Curative (C) | 2018-03-20 | 2018-04-17 | CARBOPLATIN + EPIRUBICIN + ETOPOSIDE + MELPHALAN | null | N | 260029877 | VIP |
| 260016941 | 260009855 | 0 | 93 | Palliative (P) | 2016-11-24 | 2016-12-04 | CARBOPLATIN + ETOPOSIDE | 02 | N | 260029894 | BLEOMYCIN |
| 260016942 | 260009856 | null | 88.6 | Curative (C) | 2017-09-24 | 2017-09-27 | CHOP - 21 days | 2 | N | 260029894 | TRASTUZUMAB |
| 260016943 | 260009861 | 1.68 | 64 | Curative (C) | 2016-11-18 | 2017-01-11 | Pemetrexed | null | N | 260029943 | CYTARABINE HD + METHOTREXATE HD |
| 260016944 | 260009863 | 1.62 | 72 | Palliative (P) | 2016-11-01 | 2016-11-01 | BLEOMYCIN + VINCRISTINE | 02 | N | 260029958 | CVP |
| 260016945 | 260009865 | 1.73 | 62.6 | Palliative (P) | 2017-06-08 | 2017-08-10 | ICE | N | N | 260029960 | CVP |
| 260016946 | 260009871 | 1.83 | null | Palliative (P) | 2015-10-31 | 2015-12-01 | Carboplatin + Etoposide iv&po | N | N | 260029988 | BLEOMYCIN |
| 260016947 | 260009874 | null | 70 | null | 2014-10-13 | 2014-10-14 | BLEOMYCIN + VINCRISTINE | N | N | 260030000 | CARBO + THIOTEPA + TOPOTECAN |
| 260016948 | 260009875 | 1.6 | 105 | Palliative (P) | 2017-06-05 | 2017-06-11 | CYCLOPHOSPHAMIDE | N | N | 260030004 | AXITINIB |
| 260016949 | 260009877 | 1.76 | 65 | Curative (C) | 2017-11-15 | 2017-11-18 | ICE | 02 | N | 260030014 | CISPLATIN |
| 260016950 | 260009878 | 1.65 | 49 | Palliative (P) | 2016-02-18 | 2016-02-23 | PEMBROLIZUMAB | 02 | N | 260030019 | IPO |
| 260016951 | 260009883 | null | null | Palliative (P) | 2015-08-28 | 2015-10-25 | Methotrexate + Folinic acid | N | null | 260030030 | TEMOZOLOMIDE |
| 260016952 | 260009884 | 1.79 | 87.5 | Curative (C) | null | 2017-07-11 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE | N | N | 260030041 | CARBOPLATIN + ETOPOSIDE |
| 260016953 | 260009885 | 1.98 | 90.5 | Curative (C) | 2015-12-05 | 2015-12-13 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 260030042 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260016954 | 260009887 | 1.84 | 126.5 | Curative (C) | 2017-08-01 | 2017-08-05 | CISPLATIN + ETOPOSIDE + PACLITAXEL | 2 | Y | 260030043 | IVA |
| 260016955 | 260009888 | 1.77 | null | Palliative (P) | 2015-08-21 | 2015-08-25 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 02 | N | 260030059 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260016956 | 260014701 | 1.8 | 88.5 | Palliative (P) | 2018-11-23 | 2018-11-23 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL | N | N | 260030065 | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + METHOTREXATE |
| 260016957 | 260009890 | 1.61 | 63.6 | Curative (C) | 2018-12-26 | 2018-12-27 | VIP | 02 | N | 260030070 | EP |
| 260016959 | 260009896 | 1.86 | 95.9 | Curative (C) | 2017-06-15 | 2017-06-27 | CISPLATIN + METHOTREXATE + VINCRISTINE | 2 | N | 260030077 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 260016960 | 260009898 | 1.74 | 67.4 | Curative (C) | 2016-01-19 | 2016-01-24 | POMB/ACE | 2 | N | 260030080 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260016961 | 260009902 | null | 69 | Curative (C) | null | 2015-06-01 | FEC 60 or 75 | Y | N | 260030095 | DOCETAXEL + TRASTUZUMAB |
| 260016962 | 260009905 | null | null | Curative (C) | 2017-09-19 | 2017-10-16 | Cyclophosphamide High Dose | N | N | 260030098 | TRASTUZUMAB |
| 260016963 | 260009906 | 1.65 | 73 | Curative (C) | 2014-03-16 | 2014-04-05 | VIP | 2 | N | 260030114 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260016964 | 260009906 | 1.77 | null | Palliative (P) | 2014-07-15 | 2015-02-17 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 260030114 | GEMCITABINE + OXALIPLATIN |
| 260016965 | 260019113 | 1.64 | 72.1 | Palliative (P) | 2016-01-23 | 2016-01-28 | CVP | 2 | N | 260030118 | BLEOMYCIN + VINCRISTINE |
| 260016966 | 260019113 | 1.79 | 64.4 | Palliative (P) | 2017-09-18 | 2017-09-25 | CISPLATIN + GEMCITABINE + RITUXIMAB | N | N | 260030118 | DOCETAXEL |
| 260016967 | 260009909 | 1.7 | null | Disease modification (D) | 2014-03-06 | 2014-03-08 | Gemcitabine + Oxaliplatin | N | null | 260030125 | BLEOMYCIN |
| 260016968 | 260009911 | null | null | Palliative (P) | 2015-09-25 | 2015-09-26 | IVA | N | N | 260030127 | CHLORAMBUCIL + RITUXIMAB |
| 260016970 | 260009914 | 1.83 | 97 | Curative (C) | 2018-03-13 | 2018-03-14 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL | N | N | 260030140 | IPO |
| 260016971 | 260009914 | null | 70 | Curative (C) | 2016-03-11 | 2016-03-23 | IVE | 02 | N | 260030140 | CYCLOPHOSPHAMIDE |
| 260016972 | 260009916 | 1.53 | 74 | Curative (C) | 2013-11-04 | 2013-11-12 | Cyclophosphamide High Dose | 02 | N | 260005528 | TRASTUZUMAB |
| 260016973 | 260009918 | 1.75 | 75.8 | Disease modification (D) | 2018-05-25 | 2018-06-08 | Gemcitabine + Oxaliplatin | 2 | N | 260005534 | CARBOPLATIN + THIOTEPA + TOPOTECAN |
| 260016974 | 260009919 | 1.73 | 52.3 | Palliative (P) | 2018-07-09 | 2018-07-14 | CHOP - 21 days | N | N | 260005592 | CISPLATIN |
| 260016975 | 260009921 | 1.57 | 52 | Curative (C) | 2018-12-20 | 2018-12-30 | CYCLOPHOSPHAMIDE + FLUDARABINE | 02 | N | 260005973 | NIVOLUMAB |
| 260016976 | 260009924 | 1.78 | 57.1 | Disease modification (D) | 2018-10-10 | 2018-12-03 | TRASTUZUMAB | N | N | 260006047 | CISPLATIN + RT |
| 260016977 | 260009926 | 1.86 | 47.3 | Curative (C) | 2018-05-11 | 2018-05-15 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 260006047 | GEMCARBO |